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In 2009, the world mobilized against the threat of pandemic
influenza, which infected close to half a million individuals
and killed approximately 15,000 others; however, the world
cannot get its act together to tackle chronic diseases that
affect hundreds of millions of people worldwide and which,
in 2008 alone, killed more than 30 million individuals (1).
hronic diseases, including cardiovascular diseases (CVD),
ancer, diabetes, and chronic respiratory diseases, account
or close to one-half of the world’s global burden of disease.
t is expected that by 2030, 7 of 10 deaths worldwide will be
ue to chronic diseases, and CVD will account for the
argest share of these deaths. Currently, myocardial infarc-
ion and strokes account for approximately 12 million
eaths worldwide each year. Although chronic disease
ortality has been decreasing in most high-income coun-
ries of the world for many decades, the reverse is true in
ow- and middle-income countries (LMIC), which experi-
nce annually 9 million deaths owing to these diseases
mong people younger than age 60 years.
See page 1765
Just 23 countries, including 10 from Asia and Southeast
Asia, account for 80% of the chronic disease burden and for
more than 70% of all noncommunicable disease deaths
among individuals younger than age 70 years in LMIC (1).
*Editorials published in the Journal of the American College of Cardiology reflect the
views of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Department of Epidemiology, Biostatistics and Occupational Health,
cGill University, Montreal, Quebec, Canada; ‡Research Institute of the McGill
niversity Health Center and Institut National de Santé Publique du Québec,
ontreal, Quebec, Canada; and the §Institut Universitaire de Médecine Sociale et
réventive, Université de Lausanne, Lausanne, Switzerland. The authors have
feported that they have no relationships to disclose.India is one of these 23 countries, and its more than 1
billion people are experiencing CVD morbidity and mor-
tality at an accelerated rate and at younger ages than in
Western countries (2). The country’s economic growth, one
of the highest in the world, is raising the standard of living
of millions of citizens who are joining the expanding ranks
of a new middle class. Several other Asian countries, most
notably China and Indonesia, are following similar paths
and pursuing steep global domestic product growth as a
means to lift tens of millions of citizens out of poverty,
promote local development, and improve quality of life. The
rapid economic growth being experienced by several LMIC
leads to social and economic strains, including increases in
income disparities, migration from rural to urban centers,
insufficient infrastructures (e.g., transport, housing, sanita-
tion), and social and familial disruptions. If general im-
provements in sanitation, vaccination, and control of com-
municable diseases raise life expectancy, they also increase
the number of individuals at risk for developing chronic
diseases. In addition, the rapid pace of urbanization results
in major changes in lifestyles, including a reduction in
physical activity and energy expenditure, an increase in the
consumption of a pro-atherogenic diet, and increased to-
bacco use. The INTERHEART and INTERSTROKE
studies showed that, in all regions of the world, both
ischemic heart disease and stroke share many of the same
risk factors, including smoking, obesity, hypertension, dys-
lipidemia, diabetes, low consumption of fruits and vegeta-
bles, and physical inactivity (3,4).
Rapid development and the resulting changes in the
ocial fabric and physical environment are driving the CVD
nd other chronic diseases epidemic in LMIC. However,
he steep increase in prevalence of these diseases and the
oung age at which they occur may ultimately slow eco-
omic growth because premature deaths and disability lead
o declines in the active work force and reduction in
roductivity. In addition, increased healthcare costs will
orsen poverty because families have to pay for more
ong-term healthcare services, pharmacologic treatments,
nd rehabilitation, and these costs will add severe strains to
imited resources devoted to national healthcare expendi-
ures. It is a sad paradox that more than 50 years of progress
n the fight against CVD in most of the Western world is
eing superseded by the rapidly rising death toll of CVD
nd other chronic diseases in many LMIC.
The capacity of LMIC to respond adequately to the
hallenge of chronic diseases is affected by limited financial,
uman, and infrastructure resources. Many LMIC have few
igh-quality population level data, limited research infra-
tructures, incomplete registration of births and deaths,
nsufficient surveillance systems for diseases of public health
mportance, and few resources for population-wide health
nd social surveys. This is why the report by Huffman et al.
5) in this issue of the Journal on the incidence of CVD risk
actors from the Indian Birth Cohort is timely and sheds
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The investigators reported that among 1,100 young adult
participants (mean age at baseline 29 years) followed for an
average of 7 years, the average annual incidence of obesity
was 2.0% in men and 2.2% in women. Average hypertension
incidence was 4.2% and 1.8% per year and the incidence of
diabetes was 1.0% and 0.5% per year in men and women,
respectively. By the end of follow-up, the mean body mass
index was 27 kg/m2 in both sexes, and the prevalence of
central obesity as defined by the International Diabetes
Federation for South Asian populations (a waist circumfer-
ence of 90 cm for men or 80 cm in women) was 71%
and 70% for men and women, respectively. The prevalence
of hypertension tripled in men and women (reaching 34%
and 15%, respectively), whereas the prevalence of diabetes
doubled, reaching 12% in men and 7% in women at a mean
age of only 36 years.
There are an estimated 32 million people in India living
with ischemic heart disease (6). The high incidence of CVD
risk factors reported by Huffman et al. (5) suggest that these
numbers are likely to increase substantially over the next
several decades. For instance, the prevalence of diabetes,
already the highest in the world (7), is expected to reach
more than 80 million within the next 20 years. The
seriousness of the consequences of these increasing risk
factors should not be underestimated. The looming disease
burden for India and for many other LMIC could over-
whelm healthcare systems, which are struggling with the
still prevalent communicable diseases. The impact on local
families, worker productivity, international competitiveness
in the global economy, and continued growth could be
catastrophic and lead to serious social upheavals. The size of
the epidemic requires urgent public health, policy, and
healthcare responses.
How best to intervene though? Health education alone
will have little impact on the epidemic because smoking,
sedentariness, and poor diet do not arise in a vacuum but are
determined to a great extent by social forces that act at the
local, national, and international levels and that are strongly
linked to social and economic development, urbanization,
education, and income (8). Primordial prevention is likely
the ideal option in the long term. It aims to prevent the
occurrence of the risk factors themselves (9) by optimizing
lifestyles that are associated with low blood pressure and
cholesterol, ideal body weight, and nonsmoking. Such
strategy requires tackling the roots of CVD risk factors by
health promotion, healthy public policies, and improved
physical environments conducive to healthy lifestyles
throughout the whole life course, from conception to older
age. The millions of individuals with risk factors and disease
require adaptation of healthcare delivery systems, strength-
ening of primary care, training and deployment of local
health practitioners, development of referral and informa-
tion systems, production of practice guidelines adapted to
the realities of LMIC, development of simple diagnostic
technologic tools, and implementation of low-cost pharma-cologic and nonpharmacologic treatments and evaluation
and monitoring systems.
The LMIC need integrated approaches to tackle the
common risk factors for chronic diseases. Realizing this
necessary confluence of interest, the World Heart Federa-
tion, International Diabetes Federation, International
Union Against Tuberculosis and Lung Disease, and Union
for International Cancer Control recently created the Non-
Communicable Disease Alliance to drive a global civil/
society movement to address these diseases (10). The
Alliance will need to mobilize experts from around the
world to support the development, implementation, and
evaluation of intervention efforts ranging from public health
and healthy public policy to treatment of patients with
chronic diseases. The American College of Cardiology,
American Heart Association, and their sister organizations
in the United States, Canada, and other high-income
countries, as well as their respective members, need to draw
upon their unique expertise and resources to assist in the
global fight against CVD and chronic diseases worldwide.
Innovations have recently been proposed including strat-
egies for dietary sodium reduction and tobacco control,
which could prevent more than 1 million deaths per year in
LMIC at a cost of approximately US$0.50 per person per
year (11), and the use of aspirin and low-cost, off-patent
rugs for hypertension and hypercholesterolemia among
atients at high absolute risk of CVD, which could lead to
million fewer deaths per year at a cost of approximately
S$1.00 per person per year (12). Use of safe and inexpen-
ive pharmacologic therapies in fixed-dose combination,
uch as the polypill, is another promising avenue for the
revention of CVD (13). More recent reports have pro-
osed new affordable public health and healthcare recom-
endations with a high potential for impact (14–16).
The task is daunting, but we have a moral obligation to
support the global fight against CVD and chronic diseases,
which are the pandemic of the twenty-first century.
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